Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design, Synthesis and Biological Evaluation of 2-Phenyl Indole Analogues of OXi8006 as Colchicine Site Inhibitors of Tubulin Polymerization and Vascular Disrupting Agents.
Vairin R, Tamminga C, Shi Z, Borchardt C, Jambulapati J, Bai R, Wanniarachchi H, Bueno L, Hamel E, Mason RP, Trawick ML, Pinney KG. Vairin R, et al. Among authors: trawick ml. Bioorg Med Chem. 2024 Nov 7;118:117981. doi: 10.1016/j.bmc.2024.117981. Online ahead of print. Bioorg Med Chem. 2024. PMID: 39667146
Synthesis and biological evaluation of structurally diverse 6-aryl-3-aroyl-indole analogues as inhibitors of tubulin polymerization.
Ren W, Deng Y, Ward JD, Vairin R, Bai R, Wanniarachchi HI, Hamal KB, Tankoano PE, Tamminga CS, Bueno LMA, Hamel E, Mason RP, Trawick ML, Pinney KG. Ren W, et al. Among authors: trawick ml. Eur J Med Chem. 2024 Jan 5;263:115794. doi: 10.1016/j.ejmech.2023.115794. Epub 2023 Sep 6. Eur J Med Chem. 2024. PMID: 37984295 Free PMC article.
Demonstrating Tumor Vascular Disrupting Activity of the Small-Molecule Dihydronaphthalene Tubulin-Binding Agent OXi6196 as a Potential Therapeutic for Cancer Treatment.
Liu L, Schuetze R, Gerberich JL, Lopez R, Odutola SO, Tanpure RP, Charlton-Sevcik AK, Tidmore JK, Taylor EA, Kapur P, Hammers H, Trawick ML, Pinney KG, Mason RP. Liu L, et al. Among authors: trawick ml. Cancers (Basel). 2022 Aug 30;14(17):4208. doi: 10.3390/cancers14174208. Cancers (Basel). 2022. PMID: 36077745 Free PMC article.
Bioreductively Activatable Prodrug Conjugates of Combretastatin A-1 and Combretastatin A-4 as Anticancer Agents Targeted toward Tumor-Associated Hypoxia.
Winn BA, Devkota L, Kuch B, MacDonough MT, Strecker TE, Wang Y, Shi Z, Gerberich JL, Mondal D, Ramirez AJ, Hamel E, Chaplin DJ, Davis P, Mason RP, Trawick ML, Pinney KG. Winn BA, et al. Among authors: trawick ml. J Nat Prod. 2020 Apr 24;83(4):937-954. doi: 10.1021/acs.jnatprod.9b00773. Epub 2020 Mar 20. J Nat Prod. 2020. PMID: 32196334 Free PMC article.
50 results